Prior exposure to the elevated plus-maze sensitizes mice to the acute behavioral effects of fluoxetine and phenelzine (Q40610918)

22 September 2017

Prior exposure to the elevated plus-maze sensitizes mice to the acute behavioral effects of fluoxetine and phenelzine (English)

1 reference

22 September 2017

1 reference

1 reference

Andrew Holmes

1

1 reference

PubMed ID

12524150

22 September 2017

R John Rodgers

series ordinal

2

1 reference

PubMed ID

12524150

22 September 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

European Journal of Pharmacology

22 September 2017

1 reference

22 September 2017

459

1 reference

22 September 2017

2-3

1 reference

22 September 2017

221-230

1 reference

Limitations to enhancing the speed of onset of antidepressants - are rapid action antidepressants possible?

22 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

How does pindolol improve antidepressant action?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

Current treatments of the anxiety disorders in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

Effects of chronic antidepressants in an operant conflict procedure of anxiety in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

An investigation of the mechanisms responsible for acute fluoxetine-induced anxiogenic-like effects in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

Cloning and expression of a functional serotonin transporter from rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

Defense system psychopharmacology: an ethological approach to the pharmacology of fear and anxiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

Serotoninergic but not noradrenergic neurons in rat central nervous system adapt to long-term treatment with monoamine oxidase inhibitors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

Role of somatodendritic 5-HT autoreceptors in modulating 5-HT neurotransmission.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

A schematic representation of the psychopharmacological profile of antidepressants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

Anxiolytic-like effect of way-100635 microinfusions into the median (but not dorsal) raphe nucleus in mice exposed to the plus-maze: influence of prior test experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

Effects of benzodiazepine receptor partial inverse agonists in the elevated plus maze test of anxiety in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

A proposed test battery and constellations of specific behavioral paradigms to investigate the behavioral phenotypes of transgenic and knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

Behavioral effects of diazepam in the murine plus-maze: flumazenil antagonism of enhanced head dipping but not the disinhibition of open-arm avoidance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

Evidence that the anxiolytic-like effects of chlordiazepoxide on the elevated plus maze are confounded by increases in locomotor activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

Effect of chronic deuterated and non-deuterated phenelzine on rat brain monoamines and monoamine oxidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

The influence of open arm ledges and maze experience in the elevated plus-maze.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

One-trial tolerance to the anxiolytic effects of chlordiazepoxide in the plus-maze.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

The interplay of learning and anxiety in the elevated plus-maze

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

Factors controlling measures of anxiety and responses to novelty in the mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

Anxiolytic effects in the plus-maze of 5-HT1A-receptor ligands in dorsal raphé and ventral hippocampus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

"One-trial tolerance" to the anxiolytic actions of benzodiazepines in the elevated plus-maze, or the development of a phobic state?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

Characterisation of the phenomenon of "one-trial tolerance" to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

Raised corticosterone in the rat after exposure to the elevated plus-maze.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

Comparative study of pre- and postsynaptic 5-HT1A receptor modulation of anxiety in two ethological animal tests.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

Role of the basolateral nucleus of the amygdala in the formation of a phobia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

Risk assessment behaviour: evaluation of utility in the study of 5-HT-related drugs in the rat elevated plus-maze test.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

Behavioral effects of phenelzine in an experimental model for screening anxiolytic and anti-panic drugs: correlation with changes in monoamine-oxidase activity and monoamine levels.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of ?fear?-motivated behaviour

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

Influence of prior experience on mice behavior using the four-plate test.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

A review of the validity and variability of the elevated plus-maze as an animal model of anxiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

Targeted gene mutation approaches to the study of anxiety-like behavior in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

Responses of Swiss-Webster mice to repeated plus-maze experience: further evidence for a qualitative shift in emotional state?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

Influence of spatial and temporal manipulations on the anxiolytic efficacy of chlordiazepoxide in mice previously exposed to the elevated plus-maze

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

Prior test experience compromises the anxiolytic efficacy of chlordiazepoxide in the mouse light/dark exploration test.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

Behavioral profile of wild mice in the elevated plus-maze test for anxiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

Profiles of the antipanic compounds, triazolobenzodiazepines and phenelzine, in two animal tests of anxiety.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

Effects of phenelzine and imipramine on the steady-state levels of mRNAs that encode glutamic acid decarboxylase (GAD67 and GAD65), the GABA transporter GAT-1 and GABA transaminase in rat cortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

Reversible and irreversible monoamine oxidase inhibitors in other psychiatric disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

The use of a plus-maze to measure anxiety in the mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

Short-term cotherapy with clonazepam and fluoxetine: anxiety, sleep disturbance and core symptoms of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

Monoamine oxidase inhibitors reduce conditioned fear stress-induced freezing behavior in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

Electrophysiologic analysis of antidepressant drug effects on the GABA(A) receptor complex based upon antagonist-induced encephalographic power spectrum changes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

Differential anxiolytic efficacy of a benzodiazepine on first versus second exposure to a predatory odor in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

The use of behavioral test batteries: effects of training history.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

Effects of intra-hippocampal infusion of WAY-100635 on plus-maze behavior in mice. Influence of site of injection and prior test experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

New insights into the role of the GABA(A)-benzodiazepine receptor in psychiatric disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

Effects of the antidepressant/antipanic drug phenelzine and its putative metabolite phenylethylidenehydrazine on extracellular gamma-aminobutyric acid levels in the striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

Animal models of ??anxiety??: where next?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

Influence of prior maze experience on behaviour and response to diazepam in the elevated plus-maze and light/dark tests of anxiety in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

Effects of diazepam on behavioural and antinociceptive responses to the elevated plus-maze in male mice depend upon treatment regimen and prior maze experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

Ethopharmacological analysis of the effects of putative 'anxiogenic' agents in the mouse elevated plus-maze.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

Plus-maze retest profile in mice: importance of initial stages of trail 1 and response to post-trail cholinergic receptor blockade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

Resistance of experientially-induced changes in murine plus-maze behaviour to altered retest conditions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

Corticosterone response to the plus-maze: high correlation with risk assessment in rats and mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

Pharmacological blockade or genetic deletion of substance P (NK(1)) receptors attenuates neonatal vocalisation in guinea-pigs and mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

Application of brain microdialysis to study the pharmacology of the 5-HT1A autoreceptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

Fluoxetine tenth anniversary update: the progress continues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

Common effects of chronically administered antipanic drugs on brainstem GABA(A) receptor subunit gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

The GABA(A) receptor complex as a target for fluoxetine action.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

Crouching as an index of fear

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

inferred from DOI database lookup

7 January 2021

based on heuristic

The antidepressant drug phenelzine produces antianxiety effects in the plus-maze and increases in rat brain GABA.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Serotonin and anxiety: current models

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902874-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(02)02874-1

1 reference

22 September 2017

1 reference

PubMed ID

12524150